State Street Corp Novo Cure LTD Transaction History
State Street Corp
- $2.59 Trillion
- Q2 2025
A detailed history of State Street Corp transactions in Novo Cure LTD stock. As of the latest transaction made, State Street Corp holds 2,678,072 shares of NVCR stock, worth $30.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,678,072
Previous 2,588,716
3.45%
Holding current value
$30.4 Million
Previous $46.1 Million
3.34%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding NVCR
# of Institutions
283Shares Held
77.5MCall Options Held
943KPut Options Held
155K-
Black Rock Inc. New York, NY12.1MShares$138 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.8MShares$122 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT6.9MShares$78.3 Million9.53% of portfolio
-
Capital World Investors Los Angeles, CA6.38MShares$72.4 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA2.44MShares$27.7 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.19B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...